Statins for the primary prevention of cardiovascular disease

Fiona Taylor; Mark D. Huffman; Ana Filipa Macedo; Theresa HM Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim; Hawkins Gay

doi:10.1002/14651858.cd004816.pub5

Abstract

Reductions in all-cause mortality, major vascular events and revascularisations were found with no excess of adverse events among people without evidence of CVD treated with statins.

Keywords

MedicineCochrane LibraryDiseaseStroke (engine)PlaceboMEDLINEStatinMeta-analysisClinical trialRandomized controlled trialData extractionEmergency medicineInternal medicinePhysical therapyIntensive care medicineAlternative medicine

Affiliated Institutions

Related Publications

Meta‐analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes

Bernard M.Y. Cheung , I Lauder , Chu‐Pak Lau +1 more

Aims Since 2002, there have been five major outcome trials of statins reporting findings from more than 47 000 subjects. As individual trial results differed, we performed a met...

2004 British Journal of Clinical Pharmacology 298 citations

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

James Shepherd , Gerard J. Blauw , Michael Murphy +17 more

Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not fully established. Ou...

2002 The Lancet 3358 citations

Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

Paul M. Ridker

Twenty-two years ago, the landmark 4S trial demonstrated that statin therapy could reduce rates of recurrent myocardial infarction, stroke, and cardiovascular death among second...

2016 European Heart Journal 255 citations

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

S. Féasson

Throughout the usual LDL cholesterol range in Western populations, lower blood concentrations are associated with lower cardiovascular disease risk. In such populations, therefo...

2002 The Lancet 6959 citations

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

Rory Collins , Jane Armitage , Sarah Parish +2 more

Individuals with diabetes are at increased risk of cardiovascular morbidity and mortality, although typically their plasma concentrations of LDL cholesterol are similar to those...

2003 The Lancet 2888 citations

Publication Info

Year: 2013
Type: review
Volume: 2021
Issue: 9
Pages: CD004816-CD004816
Citations: 1817
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Statins for the primary prevention of cardiovascular disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1817

OpenAlex

Cite This

APA Style

                            
                                
                                    Fiona Taylor, 
                                
                                    Mark D. Huffman, 
                                
                                    Ana Filipa Macedo
                                
                                et al.
                            
                            (2013). 
                            Statins for the primary prevention of cardiovascular disease. 
                            Cochrane Database of Systematic Reviews
                            , 2021
                            (9)
                            , CD004816-CD004816.
                            https://doi.org/10.1002/14651858.cd004816.pub5
                        

Identifiers

DOI: 10.1002/14651858.cd004816.pub5